MicroCyto Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $220M

  • Investors
  • 16

MicroCyto General Information

Description

Manufacturer and Developer of biotechnology solutions intended for human and animal nutrition, and chemical materials. The company's products mainly focus on synthetic biotechnology and commit to using low-carbon, energy-saving, and sustainable methods to produce various compounds for use in medicine, daily chemicals, agriculture, food, feed, and materials, and other fields, providing customers with reliable and efficient products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room C223-4, 2nd Floor, Building 2, Number 9, Yike Road
  • Life Science Park, Changping District
  • Beijing, 102200
  • China
+86 010
Primary Industry
Multi-line Chemicals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room C223-4, 2nd Floor, Building 2, Number 9, Yike Road
  • Life Science Park, Changping District
  • Beijing, 102200
  • China
+86 010

MicroCyto Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroCyto Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 13-May-2026 $220M Completed Generating Revenue
5. Early Stage VC (Series A1) 04-Jan-2026 Completed Generating Revenue
4. Early Stage VC (Series A) 29-Aug-2024 Completed Generating Revenue
3. Early Stage VC 16-Aug-2023 Completed Generating Revenue
2. Early Stage VC 15-Jun-2023 Completed Generating Revenue
1. Seed Round 30-May-2022 Completed Startup
To view MicroCyto’s complete valuation and funding history, request access »

MicroCyto Patents

MicroCyto Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026219236-A1 Multi-site chromosome editing tool and use thereof Pending 16-Apr-2025
WO-2026039994-A1 Recombinant escherichia coli for producing d-psicose, and preparation method therefor Pending 20-Aug-2024

MicroCyto Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicroCyto Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Zhongguancun Capital Fund Management Growth/Expansion Minority
Jianxin Financial Asset Investment Asset Manager Minority
Beijing Qijian Private Equity Fund Management Growth/Expansion Minority
Beijing State-owned Capital Operation and Management Government Minority
Shenzhen Capital Group Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

MicroCyto FAQs

  • When was MicroCyto founded?

    MicroCyto was founded in 2021.

  • Where is MicroCyto headquartered?

    MicroCyto is headquartered in Beijing, China.

  • What is the size of MicroCyto?

    MicroCyto has 100 total employees.

  • What industry is MicroCyto in?

    MicroCyto’s primary industry is Multi-line Chemicals.

  • Is MicroCyto a private or public company?

    MicroCyto is a Private company.

  • What is MicroCyto’s current revenue?

    The current revenue for MicroCyto is .

  • How much funding has MicroCyto raised over time?

    MicroCyto has raised $306M.

  • Who are MicroCyto’s investors?

    Beijing Zhongguancun Capital Fund Management, Jianxin Financial Asset Investment, Beijing Qijian Private Equity Fund Management, Beijing State-owned Capital Operation and Management, and Shenzhen Capital Group are 5 of 16 investors who have invested in MicroCyto.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process